Cargando…
Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 That Was Successfully Treated with Regorafenib
An unconscious 55-year-old man with a history of neurofibromatosis type 1 (NF1) was transported to the emergency department and was diagnosed with acute renal failure owing to a large bladder tumor. A submucosal tumor was also identified in the duodenum. The patient was diagnosed with a primary gast...
Autores principales: | Fujimi, Akihito, Nagamachi, Yasuhiro, Yamauchi, Naofumi, Tamura, Fumito, Kimura, Tomohiro, Miyajima, Naoya, Inomata, Hidetoshi, Nishisato, Takuji, Yoshida, Makoto, Takada, Kohichi, Kobayashi, Ko, Kato, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663552/ https://www.ncbi.nlm.nih.gov/pubmed/30918185 http://dx.doi.org/10.2169/internalmedicine.2321-18 |
Ejemplares similares
-
Acute Abdomen and Adrenal Swelling as the First Manifestations of TAFRO Syndrome
por: Fujimi, Akihito, et al.
Publicado: (2022) -
Morphological Transformation of Myeloma Cells into Multilobated Plasma Cell Nuclei within 7 Days in a Case of Secondary Plasma Cell Leukemia That Finally Transformed as Anaplastic Myeloma
por: Fujimi, Akihito, et al.
Publicado: (2017) -
Targeting gastrointestinal stromal tumors: the role of regorafenib
por: Schroeder, Brett, et al.
Publicado: (2016) -
A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma
por: Ibata, Soushi, et al.
Publicado: (2016) -
Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor
por: Grellety, Thomas, et al.
Publicado: (2015)